Peripherally Inserted Central Catheters Market Size & Share 2024 to 2032

Peripherally Inserted Central Catheters Market Size

Peripherally Inserted Central Catheters Market size was valued at around USD 1.3 billion in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032. The increasing prevalence of infectious diseases and rising incidence of chronic conditions worldwide have propelled the demand for peripherally inserted central catheters (PICCs) globally.

Infectious diseases such as sepsis, pneumonia, and bloodstream infections often require prolonged intravenous therapy, necessitating the use of PICCs for reliable and long-term venous access. Additionally, the growing burden of chronic conditions such as cancer, kidney disease, and autoimmune disorders has led to an increase in the need for PICCs for chemotherapy, dialysis, and other treatments that require frequent or continuous infusion of medications and fluids.
 

For instance, according to Centers for Disease Control and Prevention (CDC), in 2019, there were 201,092 deaths in the U.S. involving sepsis, with three-fourths of those deaths occurring among persons aged 65 and over. These statistics underscore the growing demand for PICCs as a vital tool in managing both infectious diseases and chronic conditions, driving market growth for these catheters on a global scale.
 

Peripherally inserted central catheters (PICCs) are long, flexible tubes inserted into a peripheral vein, usually in the arm, and threaded through the vein until the tip reaches a large central vein near the heart, such as the superior vena cava or the inferior vena cava. PICCs are used to administer medications, fluids, blood products, or nutrients over an extended period, typically weeks to months, and can also be used for blood draws and to monitor central venous pressure.
 

Peripherally Inserted Central Catheters Market Trends

Advancements in peripherally inserted central catheters (PICCs) have been driven by the need for safer, more reliable, and patient-friendly intravenous access.
 

• For instance, the development of antimicrobial catheter materials and coatings, which help reduce the risk of bloodstream infections associated with long-term catheter use. These antimicrobial properties inhibit bacterial growth on the catheter surface, lowering the incidence of catheter-related bloodstream infections (CRBSIs) and improving patient outcomes.
   
• Additionally, the integration of imaging technologies such as ultrasound and fluoroscopy into PICC insertion procedures, which allows healthcare providers to accurately place the catheter tip in the central venous system, minimizing the risk of malposition and complications.
   
• Moreover, advancements in catheter design, such as the use of radiopaque materials and tip-locating devices, facilitate precise catheter tip visualization during insertion and subsequent monitoring, further enhancing patient safety.
   
• Furthermore, the incorporation of innovative features such as valved catheter hubs and anti-reflux devices helps prevent blood reflux and occlusion, prolonging catheter patency and reducing the need for catheter replacements. These advancements contribute to the overall growth and adoption of PICCs in clinical practice worldwide.
   

Peripherally Inserted Central Catheters Market Analysis

Based on product, the market is categorized into power injected PICC, conventional PICC, and neonatal PICC. The power injected PICC segment dominated the market and was valued at USD 599.2 million in revenue in 2023.
 

• Power injected PICCs are specifically designed to withstand higher injection pressures, making them suitable for delivering contrast media or medications at rapid infusion rates. This feature is particularly beneficial in diagnostic imaging procedures such as computed tomography (CT) scans, where high-pressure injections are required for optimal imaging.
   
• Additionally, power-injected PICCs feature larger lumens and more robust construction, facilitating higher flow rates during infusion. This enables faster administration of fluids and medications, enhancing efficiency and patient throughput in clinical settings, thereby increasing their demand in the market.
   

Based on lumen, the peripherally inserted central catheters market is categorized into single, double, and multiple. The double lumen segment dominated the market, with the revenue of around USD 632.3 million in revenue in 2023.
 

• Double lumen catheters offer the versatility of having two lumens within a single catheter, allowing for simultaneous administration of multiple medications or fluids. This feature is particularly advantageous in critical care settings where patients may require different therapies concurrently.
   
• Additionally, using a double lumen catheter instead of other lumen types can be more cost-effective, as it eliminates the need for additional catheter kits, insertion procedures, and maintenance. This is particularly important in healthcare systems aiming to optimize resources and reduce healthcare costs, hence, contributes to its increasing demand.
   

Based on application, the peripherally inserted central catheters market is categorized into chemotherapy, long-term IV infusion, parenteral nutrition, blood transfusion, and other applications. The long-term IV infusion segment dominated the market, with the revenue of around USD 426.4 million in revenue in 2023.
 

• Long-term IV infusion refers to the administration of fluids, medications, or therapies over an extended period, typically more than a week. This application encompasses a wide range of treatments, including antibiotics, pain management, hydration, and chemotherapy, among others. As a result, it serves a broad patient population with diverse medical needs.
   
• Additionally, many patients with chronic conditions require ongoing IV therapy to manage their health. Long-term IV infusion provides a convenient and effective way to administer medications or nutrients over an extended period, allowing patients to receive treatment without frequent hospital visits, may contributes to its increasing demand for this application.

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the peripherally inserted central catheters market is categorized into hospitals, ambulatory surgical centers, home-care centers, and other end-users. The hospitals are segment held the dominant position in the market and is anticipated to reach around USD 1.2 billion in 2032.
 

• Hospitals have the infrastructure, resources, and specialized medical staff to manage patients with serious medical conditions. PICC insertion and management often require skilled healthcare professionals, making hospitals the preferred setting for these procedures.
   
• Moreover, hospital environments provide continuous monitoring and support for patients with PICCs, ensuring proper placement, function, and management of the catheters. This level of monitoring is essential for preventing complications such as infection, thrombosis, or catheter dislodgement, thereby increasing their necessity in healthcare settings such as hospitals.

North America peripherally inserted central catheters market accounted for USD 447 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America has a well-developed healthcare infrastructure with advanced hospitals, clinics, and ambulatory surgical centers. These facilities have the expertise and resources to support the insertion, management, and care of PICCs, contributing to their widespread use.
   
• Additionally, favorable reimbursement policies for PICC procedures and related services in North America incentivize healthcare providers to use PICCs for appropriate patients. Reimbursement coverage for PICC-related expenses ensures that patients have access to this essential vascular access device.
   

U.S. peripherally inserted central catheters market holds a dominant position with the market share of 92.5% in 2023.  
 

• There is a growing trend towards home-based healthcare in the U.S., driven by factors such as an aging population, healthcare cost containment, and patient preference. PICCs allow patients to receive long-term IV therapy at home, providing convenience and improving their quality of life.
   
• Additionally, according to a report by the Centers for Medicare & Medicaid Services (CMS) published in 2021, the demand for home healthcare services in the U.S. has been steadily increasing. The report indicated that the number of Medicare beneficiaries receiving home healthcare services grew by 27% from 3.5 million in 2000 to 4.5 million in 2018. This trend reflects the growing preference among patients for receiving healthcare services in the comfort of their own homes, including treatments that may require peripherally inserted central catheters (PICCs) for long-term intravenous therapy.
   

Germany peripherally inserted central catheters market is anticipated to witness notable growth during 2024-2032.
 

• Germany, like many other developed countries, has an aging population with a high prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes. These conditions often require long-term intravenous therapy, driving the demand for PICCs as a reliable vascular access option.
   
• Additionally, aging demographic in Germany contributes to the rising incidence of chronic diseases, further fueling the demand for peripherally inserted central catheters (PICCs) as a preferred vascular access option for long-term intravenous therapy.
   

China may experience a high growth potential in the peripherally inserted central catheters market.
 

• There is growing awareness among healthcare professionals and patients about the benefits of PICCs for long-term intravenous therapy. As a result, PICCs are increasingly being recognized as a preferred option for vascular access in China's healthcare system.
   
• Additionally, Chinese government's focus on improving healthcare infrastructure and promoting the adoption of advanced medical devices has also contributed to the rising acceptance of PICCs among healthcare providers and patients.
   

Peripherally Inserted Central Catheters Market Share

The peripherally inserted central catheters (PICCs) industry is competitive in nature, as large multinational corporations and smaller firms compete for dominance. Key players continuously innovate to develop novel PICCs that offer enhanced efficiency, comfort, and cost-effectiveness. This focus on innovation drives competitiveness, ensuring that PICC technology remains at the forefront of medical advancements. Manufacturers aim to expand their market share by introducing new materials, formulations, and delivery systems to meet the growing demand for advanced PICCs, ultimately improving patient outcomes and quality of life.
 

Peripherally Inserted Central Catheters Companies

Some of the eminent market participants operating in the peripherally inserted central catheters industry include:

• Access Vascular, Inc.
• AngioDynamic, Inc.
• Argon Medical
• B. Braun Medical Ltd
• Becton, Dickinson and Company
• Biowy Corporation
• Cardinal Health, Inc.
• Footprint Medical Incorporated
• ICU Medical, Inc.
• Kimal Plc
• Medi-Tech Devices
• Teleflex Incorporated
   

Peripherally Inserted Central Catheters Industry News:

• In May 2023, Teleflex Incorporated launched the new Arrow VPS Rhythm DLX Device and NaviCurve Stylet in the U.S. central catheters (PICCs). This launch enhanced the company’s product portfolio and enabled them more customer base.
   
• In September 2022, B. Braun Medical Inc. acquired the innovative Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. This acquisition enhanced B. Braun's portfolio of catheter securement solutions and improved the company’s reputation in the market.
   

Peripherally inserted central catheters market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

                                         

Market, By Product

• Power injected PICC
• Conventional PICC
• Neonatal PICC

By Lumen

• Single
• Double
• Multiple

By Applications

• Chemotherapy
• Long-term IV Infusion
• Parenteral nutrition
• Blood transfusion
• Other applications

By end-use

• Hospitals
• Ambulatory surgical centers
• Homecare settings
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa